Podcast: Play in new window | Download (Duration: 11:08 — 12.2MB)Subscribe or Follow Apple Podcasts | Spotify | RSS | MoreThis episode of Biotalk is focused on Locust Walk’s 2023 First Quarter Market Conditions Report, in which we apply the latest data to...
Each quarter, Locust Walk’s deal team compiles key statistics and trends on strategic transactions and financings. Our 2023 Frist Quarter Report applies the latest data to analyze current activities in the life sciences deal landscape.
Podcast: Play in new window | Download (Duration: 41:12 — 45.4MB)Subscribe or Follow Apple Podcasts | Spotify | RSS | MoreOn this episode of Biotalk, Locust Walk welcomes Andrew Allen, M.D., Ph.D., Co-Founder, President, CEO, and board member of Gritstone Bio to...
Locust Walk views RNA therapeutics in 5 key pillars: RNA Translation Inhibition, Protein Expression, RNA-Targeting Small Molecules, RNA Editing, and RNA-Mediated Protein and Transcriptome Regulation.
Podcast: Play in new window | Download (Duration: 13:12 — 14.7MB)Subscribe or Follow Apple Podcasts | Spotify | RSS | MoreOur first Biotalk podcast is focused on Locust Walk’s 2022 year-in-review market conditions, which was released the first day of JPMorgan...
